3 Biotech Stocks With Potential
Seeking Alpha
ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
Seeking Alpha
Submitted by moderatorj on Mon, 11/12/2012 - 23:56
ImmunoCellular Therapeutics Reports Third Quarter 2012 Financial Results
Yahoo/BusinessWire
Submitted by moderatorj on Thu, 10/18/2012 - 22:47
ImmunoCellular Therapeutics, Ltd. Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants
Yahoo/BusinessWire
Submitted by moderatorj on Wed, 09/05/2012 - 21:45
ImmunoCellular Therapeutics Completes Enrollment of Phase II Trial of ICT-107 in Glioblastoma
Yahoo/BusinessWire
Submitted by moderatorj on Mon, 08/20/2012 - 23:02
ImmunoCellular Therapeutics Appoints John S. Yu, MD, as Interim Chief Executive Officer
Yahoo/BusinessWire
Submitted by moderatorj on Wed, 08/15/2012 - 21:30
ImmunoCellular Therapeutics Reports Second Quarter Results
Yahoo/BusinessWire
Submitted by moderatorj on Mon, 08/13/2012 - 20:46
ImmunoCellular Therapeutics’ ICT-107 featured on CNN’s Sanjay Gupta MD
Yahoo/BusinessWire